Notas del episodio
About Tilray Brands
With annualized revenues of US$920Mn (May qtr annualized run rate), Tilray Brands has built a diversified portfolio of complementary assets in the cannabis, drinks (alcohol mostly, but not only), hemp food, and pharma distribution businesses. Exiting FY24, we believe the cannabis and drinks unit will each contribute about 40% of the company’s gross profits. How these various categories complement each other now, and in the future, will depend on regulatory changes and how these changes “blur the lines” between product types (say, hemp and or THC drinks). For example, a) TLRY’s expertise in medical cannabis could be a competitive advantage as more countries “liberalize” their MMJ programs (Germany and Israel are making their MMJ programs less restrictive). Also, lessons learned from the competitive Canadi ...
Palabras clave
CannabisReschedulingInvestingC SuiteTilray MarijuanadispensaryDispensariesDEA280EMSOsSchedule 3HHSschedule IIICanadaFloridaGermanyPharmacymedical cannabiseuropepatientsvapevapingvapesschedule 1Zuanic & associatesPablo ZuanicHSAInvesting CannabisIrwin SimonrepublicanDemocratsHemp DrinkshempFarm BillIsraelSafe bankingSafer bankingHemp DerivativesHemp Beverage Alliance